Literature DB >> 11698437

Deletional analysis of the murine IL-12 p35 promoter comparing IFN-gamma and lipopolysaccharide stimulation.

J Kollet1, C Witek, J D Gentry, X Liu, S D Schwartzbach, T M Petro.   

Abstract

IL-12, pivotal to the development of Th1 cells and formed by association of p35 and p40 subunits, is made by macrophages and the macrophage cell line RAW264.7. In this study, the promoter for p35 was cloned and analyzed. The murine IL-12 p35 gene has promoters upstream from each of the first two exons. The exon 1 and exon 2 promoters, cloned into a reporter vector, were responsive to LPS or IFN-gamma/CD40 ligation in transfected RAW264.7 cells. The exon 2 promoter containing bp -809 to +1 has significant homology to the human p35 promoter. Thus, deletion analysis was performed to determine the regions required for responsiveness to LPS, CD40, and/or IFN-gamma. Base pairs -809 to -740 influenced responsiveness to LPS. In contrast, bp -740to -444 and bp -122 to -100 were required for responses to IFN-gamma, IFN-gamma/LPS, or IFN-gamma/CD40 ligation. Removal of bp -444 to -392 increased the response of the exon 2 promoter to each stimulant. IFN regulatory factor (IRF)-1 is involved in the activity of this promoter at bp -108 to -103 because levels of nuclear IRF-1 correlated with exon 2 promoter activity in response to IFN-gamma and IRF-1 overexpression stimulated and enhanced exon 2 promoter activity. Also, site or deletion mutation of the IRF-1 element at bp -108 to -103 reduced the responsiveness of the promoter and IRF-1 bound to an oligonucleotide containing bp -108 to -103. The data suggest that the response of the p35 promoter to IFN-gamma requires a distinct IRF-1 positive regulatory element at bp -108 to -103.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698437     DOI: 10.4049/jimmunol.167.10.5653

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Replacement of the C-terminal tetrapeptide (314 PAPV 317 to 314 SSSM 317) in interferon regulatory factor-2 alters its N-terminal DNA-binding activity.

Authors:  Krishna Prakash; Pramod C Rath
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

2.  Expression and DNA binding activity of the recombinant interferon regulatory factor-1 (IRF-1) of mouse.

Authors:  Meenakshi Upreti; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2005-06       Impact factor: 2.316

3.  Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells.

Authors:  Asha Jayakumar; Michael J Donovan; Vinita Tripathi; Marcelo Ramalho-Ortigao; Mary Ann McDowell
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

4.  Soluble C-Type Lectin-Receptor Ligands Stimulate ROS Production in Dendritic Cells and Potentiate Killing of MRSA as Well as the MRSA Induced IL-12 Production.

Authors:  Helene M S Eld; Peter R Johnsen; Emilie M Nielsen; Frederikke Z Jørgensen; Marie Lindstrøm-Svendsen; Mara Baldry; Hanne Ingmer; Hanne Frøkiær
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

5.  The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells.

Authors:  Li-Chieh Wang; Yu-Li Lin; Yu-Chih Liang; Yao-Hsu Yang; Jyh-Hong Lee; Hsin-Hui Yu; Wen-Mein Wu; Bor-Luen Chiang
Journal:  BMC Immunol       Date:  2009-07-16       Impact factor: 3.615

6.  Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.

Authors:  Jianguo Liu; Shanjin Cao; Lisa M Herman; Xiaojing Ma
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

7.  IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3K.

Authors:  Xiaoqin Guo; Xingwei Jiang; Yan Xiao; Tingting Zhou; Yueling Guo; Renxi Wang; Zhi Zhao; He Xiao; Chunmei Hou; Lingyun Ma; Yanhua Lin; Xiaoling Lang; Jiannan Feng; Guojiang Chen; Beifen Shen; Gencheng Han; Yan Li
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.